Literature DB >> 11990808

Detection of hyperacute subarachnoid hemorrhage of the brain by using magnetic resonance imaging.

Martin Wiesmann1, Thomas E Mayer, Indra Yousry, Ralph Medele, Gerhard F Hamann, Hartmut Brückmann.   

Abstract

OBJECT: The purpose of this study was to determine the diagnostic accuracy of high-field (1.5-tesla) magnetic resonance (MR) imaging in the assessment of hyperacute (< 12 hours after onset of symptoms) subarachnoid hemorrhage (SAH).
METHODS: This investigation included 13 patients who were examined 2 to 12 hours posthemorrhage by using an MR imaging protocol consisting of T2-weighted and proton-density (PD)-weighted images, T1-weighted images, fast echoplanar-diffusion-weighted (EP-DW) images, and fluid-attenuated inversion-recovery (FLAIR) images. Subarachnoid hemorrhage had been diagnosed using computerized tomography (CT) scanning in all cases. In all 13 cases, SAH was reliably detected on both PD-weighted and FLAIR images. In contrast with FLAIR studies, the PD-weighted images were free of cerebrospinal fluid flow artifacts. The SAH was detected on T1-weighted images in only two cases and could not be detected on any T2-weighted or EP-DW images.
CONCLUSIONS: Even hyperacute SAH can be diagnosed reliably from high-field MR images obtained using PD-weighted or FLAIR sequences. Use of these sequences in an emergency MR protocol may preclude the need for additional CT studies to rule out SAH.

Entities:  

Mesh:

Year:  2002        PMID: 11990808     DOI: 10.3171/jns.2002.96.4.0684

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  13 in total

Review 1.  Diagnosis of subarachnoid hemorrhage.

Authors:  Jonathan A Edlow
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 2.  Spectrophotometry for cerebrospinal fluid pigment analysis.

Authors:  Axel Petzold; Lindsay T Sharpe; Geoffrey Keir
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

3.  3D fluid-attenuated inversion recovery imaging: reduced CSF artifacts and enhanced sensitivity and specificity for subarachnoid hemorrhage.

Authors:  N Lummel; V Schoepf; M Burke; H Brueckmann; J Linn
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

4.  Frequency and appearance of hemosiderin depositions after aneurysmal subarachnoid hemorrhage treated by endovascular therapy.

Authors:  Bernhard Falter; Martin Wiesmann; Jessica Freiherr; Omid Nikoubashman; Michael Mull
Journal:  Neuroradiology       Date:  2015-07-19       Impact factor: 2.804

5.  MR imaging of hyperacute subarachnoid and intraventricular hemorrhage at 3T: a preliminary report of gradient echo T2*-weighted sequences.

Authors:  Chul-Ho Sohn; Seung-Kug Baik; Hee-Jung Lee; Sung-Moon Lee; Il-Man Kim; Man-Bin Yim; Jae-Suk Hwang; M Louis Lauzon; Robert J Sevick
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

6.  The value of different magnetic resonance imaging sequences for the detection of intraventricular hemorrhages*.

Authors:  Nina Lummel; Martin Wiesmann; Hartmut Brückmann; Jennifer Linn
Journal:  Clin Neuroradiol       Date:  2010-02-28       Impact factor: 3.649

Review 7.  Magnetic resonance imaging: implication in acute ischemic stroke management.

Authors:  Oraporn Sitburana; Walter J Koroshetz
Journal:  Curr Atheroscler Rep       Date:  2005-07       Impact factor: 5.113

Review 8.  New magnetic resonance imaging and computed tomography techniques for imaging of acute stroke.

Authors:  Amie W Hsia; David C Tong
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

9.  MRI in acute subarachnoid haemorrhage; findings with a standardised stroke protocol.

Authors:  J B Fiebach; P D Schellinger; K Geletneky; P Wilde; M Meyer; W Hacke; K Sartor
Journal:  Neuroradiology       Date:  2003-12-04       Impact factor: 2.804

10.  Fluid-attenuated inversion recovery MR imaging and subarachnoid hemorrhage: not a panacea.

Authors:  Mona Mohamed; D Cressler Heasly; Banu Yagmurlu; David M Yousem; D Cressler Heasely
Journal:  AJNR Am J Neuroradiol       Date:  2004-04       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.